Christine Rivat

Late-Stage Clinical Development
BioMarin Pharmaceutical Inc.
Novato, California, United States

Presentation(s):

• OC 30.3 - Health-related quality-of-life outcomes 4 years after treatment with valoctocogene roxaparvovec

  Monday, June 24, 2024
  10:00 – 10:15 ICT